British Journal of Clinical Pharmacology,
Journal Year:
2021,
Volume and Issue:
88(2), P. 452 - 463
Published: June 22, 2021
Community-based
pharmacists
are
an
important
stakeholder
in
providing
continuing
care
for
chronic
multi-morbid
patients,
and
their
role
is
steadily
expanding.
The
aim
of
this
study
to
examine
the
literature
exploring
community-based
pharmacist-initiated
and/or
-led
deprescribing
evaluate
impact
on
success
clinical
outcomes.Library
trials
databases
were
searched
from
inception
March
2020.
Studies
included
if
they
explored
adults,
by
available
English.
Two
reviewers
extracted
data
independently
using
a
pre-agreed
extraction
template.
Meta-analysis
was
not
performed
due
heterogeneity
designs,
types
intervention
outcomes.A
total
24
studies
review.
Results
grouped
based
method
into
four
categories:
educational
interventions;
interventions
involving
medication
review,
consultation
or
therapy
management;
pre-defined
pharmacist-led
collaborative
interventions.
All
resulted
greater
discontinuation
medications
comparison
usual
care.
Educational
reported
financial
benefits
as
well.
Medication
review
pharmacist
can
lead
successful
high-risk
medication,
but
do
affect
risk
rate
falls,
hospitalisations,
mortality
quality
life.
Pharmacist-led
patients
with
mental
illness,
resulting
improves
anticholinergic
side
effects,
memory
Pre-defined
did
reduce
healthcare
resource
consumptions
contribute
savings.
Short
follow-up
periods
prevent
evaluation
long-term
sustainability
interventions.This
systematic
suggests
that
valuable
partners
collaborations,
necessary
monitoring
throughout
tapering
post-follow-up
ensure
intervention.
Journal of the American Medical Directors Association,
Journal Year:
2020,
Volume and Issue:
21(2), P. 181 - 187
Published: Jan. 8, 2020
ObjectivePolypharmacy
is
widespread
among
older
people,
but
the
adverse
outcomes
associated
with
it
are
unclear.
We
aim
to
synthesize
current
evidence
on
health,
social,
medicines
management,
and
health
care
utilization
of
polypharmacy
in
people.DesignA
systematic
review,
reviews
meta-analyses
observational
studies,
was
conducted.
Eleven
bibliographic
databases
were
searched
from
1990
February
2018.
Quality
assessed
using
AMSTAR
(A
Measurement
Tool
Assess
Systematic
Reviews).Setting
participantsOlder
people
any
setting,
residential
or
country.ResultsTwenty-six
reporting
230
unique
studies
included.
Almost
all
operationalized
as
medication
count,
few
examined
classes
disease
states
within
this.
Evidence
for
an
association
between
many
outcomes,
including
drug
events
disability,
conflicting.
The
most
consistent
found
hospitalization
inappropriate
prescribing.
No
research
had
explored
very
old
(aged
≥85
years),
potential
social
consequences
use,
such
loneliness
isolation.Conclusions
implicationsThe
literature
examining
complex,
extensive,
Until
a
more
clinically
relevant
manner,
will
not
be
fully
understood.
Future
should
work
toward
this
approach
face
rising
multimorbidity
population
aging.
BJGP Open,
Journal Year:
2020,
Volume and Issue:
4(3), P. bjgpopen20X101096 - bjgpopen20X101096
Published: July 28, 2020
Background
Managing
polypharmacy
is
a
challenge
for
healthcare
systems
globally.
It
also
health
inequality
concern
as
it
can
expose
some
of
the
most
vulnerable
in
society
to
unnecessary
medications
and
adverse
drug-related
events.
Care
patients
with
multimorbidity
occurs
primary
care.
Safe
deprescribing
interventions
reduce
exposure
inappropriate
polypharmacy.
However,
these
are
not
fully
accepted
or
routinely
implemented.
Aim
To
identify
barriers
facilitators
safe
adults
Design
&
setting
A
systematic
review
studies
published
from
2000,
examining
Method
search
electronic
databases:
MEDLINE,
Embase,
Cumulative
Index
Nursing
Allied
Health
Literature
(CINHAL),
Cochrane,
Management
Information
Consortium
(HMIC)
inception
26
Feb
2019,
using
an
agreed
strategy.
This
was
supplemented
by
handsearching
relevant
journals,
screening
reference
lists
citations
included
studies.
Results
In
total,
40
14
countries
were
identified.
Cultural
organisational
included:
culture
diagnosing
prescribing;
evidence-based
guidance
focused
on
single
diseases;
lack
care
older
people
multimorbidities;
shared
communication,
decision-making
systems,
tools,
resources.
Interpersonal
individual-level
professional
etiquette;
fragmented
care;
prescribers’
patients’
uncertainties;
gaps
tailored
support.
Facilitators
prudent
greater
availability
acceptability
non-pharmacological
alternatives;
resources;
improved
collaboration,
knowledge,
understanding;
patient-centred
decision-making.
Conclusion
whole
approach
required,
involving
key
decision-makers,
professionals,
patients,
carers.
The Journals of Gerontology Series B,
Journal Year:
2017,
Volume and Issue:
73(7), P. e98 - e107
Published: Oct. 16, 2017
Polypharmacy
in
the
older
population
is
increasing-and
can
be
harmful.
It
safe
to
reduce
or
carefully
cease
medicines
(deprescribing)
but
a
collaborative
approach
between
patient
and
doctor
required.
This
study
explores
decision-making
about
polypharmacy
with
adults
their
companions.
Semi-structured
interviews
were
conducted
30
people
(aged
75+
years,
taking
multiple
medicines)
15
Framework
analysis
was
used
identify
qualitative
themes.
Participants
varied
considerably
attitudes
towards
medicines,
preferences
for
involvement
decision-making,
openness
deprescribing.
Three
types
identified.
Type
1
held
positive
preferred
leave
decisions
doctor.
2
voiced
ambivalent
proactive
role,
open
3
frail,
perceived
they
lacked
knowledge
deferred
most
companion.
provides
novel
typology
describe
differences
who
are
happy
take
those
To
enable
shared
prescribers
need
adapt
communication
based
on
patients'
decisions.
Every
day,
750
older
people
living
in
the
United
States
(age
65
and
older)
are
hospitalized
due
to
serious
side
effects
from
one
or
more
medications.
1Over
last
decade,
sought
medical
treatment
visited
emergency
room
than
35
million
times
for
adverse
drug
events,
there
were
2
hospital
admissions
events
(see
Appendix
A,
p.
40).
Older
adults
at
a
greater
rate
general
population
is
opioids.
3In
past
prescribing
multiple
medications
individual
patients
(called
"polypharmacy"
scientific
literature)
has
reached
epidemic
proportions.More
four
ten
take
five
prescription
an
increase
of
300
percent
over
two
decades.
4Nearly
20
drugs
more.When
over-thecounter
supplements
included,
number
taking
rises
67
percent.
5Medications
have
improved
lives
individuals
around
world,
many
benefit
drugs.Indeed,
polypharmacy
may
be
necessary
who
chronic
disease.However,
also
greatly
increases
person's
risk
suffering
serious,
sometimes
life-threatening
effect.Over
few
decades,
medication
use
U.S.,
especially
people,
gone
far
beyond
polypharmacy,
point
where
millions
overloaded
with
too
prescriptions
experiencing
significant
harm
as
result.*
An
reaction
defined
negative
prescribed.Adverse
include
reactions,
but
non-regular
medication,
such
errors
overdoses.
BMC Family Practice,
Journal Year:
2020,
Volume and Issue:
21(1)
Published: July 1, 2020
General
practitioners
(GPs)
increasingly
manage
patients
with
multimorbidity
but
report
challenges
in
doing
so.
Patients
describe
poor
experiences
health
care
systems
that
treat
each
of
their
conditions
separately,
resulting
fragmented,
uncoordinated
care.
For
GPs
to
provide
the
patient-centred,
coordinated
need
and
want,
research
agendas
system
structures
policies
will
adapt
address
this
epidemiologic
transition.
This
systematic
review
seeks
understand
if
how
impacts
on
work
GPs,
strategies
they
employ
challenges,
what
believe
still
needs
addressing
ensure
quality
patient
care.Systematic
thematic
synthesis
qualitative
studies
reporting
GP
managing
multimorbidity.
The
search
included
nine
major
databases,
grey
literature
sources,
Google
Scholar,
a
hand
Journal
Comorbidity,
reference
lists
studies.Thirty-three
from
fourteen
countries
were
included.
Three
identified:
practising
without
supportive
evidence;
working
within
fragmented
whose
remain
organised
around
single
condition
specialisation;
clinical
uncertainty
associated
complexity
general
practitioner
perceptions
decisional
risk.
revealed
three
approaches
mitigating
these
challenges:
prioritising
patient-centredness
relational
continuity;
relying
knowledge
preferences
unique
circumstances
individualise
care;
structuring
consultation
create
sense
time
minimise
risk.GPs
described
an
ongoing
tension
between
applying
guidelines
as
security
against
or
penalty,
potentially
causing
harm.
Above
all,
chose
prioritise
long-term
relationships
for
numerous
gains
brought
such
mutual
trust,
deeper
insight
into
patient's
circumstances,
useable
individual's
capacity
illness
goals
life.
better
management
guidance.
Perhaps
more
than
this,
require
models
practice
remunerated
space
nurturing
trustful
therapeutic
partnerships.
Expert Review of Clinical Pharmacology,
Journal Year:
2020,
Volume and Issue:
13(3), P. 233 - 245
Published: Feb. 14, 2020
Introduction:
There
is
increasing
recognition
of
the
need
for
deprescribing
inappropriate
medications
in
older
adults.
However,
efforts
to
encourage
implementation
clinical
practice
have
resulted
mixed
results
across
settings
and
countries.Area
covered:
Searches
were
conducted
PubMed,
Embase,
Google
Scholar
June
2019.
Reference
lists,
citation
checking,
personal
reference
libraries
also
utilized.
Studies
capturing
main
challenges
of,
opportunities
for,
implementing
into
selected
health-care
internationally,
international
deprescribing-orientated
policies
included
summarized
this
narrative
review.Expert
opinion:
Deprescribing
intervention
studies
are
inherently
heterogeneous
because
complexity
interventions
employed
often
do
not
reflect
real-world.
Further
research
investigating
enhanced
required.
Process
evaluations
needed
determine
contextual
factors
that
important
translation
may
be
individually
tailored
target
unique
barriers
different
settings.
Introduction
national
beneficial,
but
evaluated
if
there
any
unintended
consequences.
The Journals of Gerontology Series A,
Journal Year:
2021,
Volume and Issue:
77(5), P. 1020 - 1034
Published: Aug. 14, 2021
Abstract
Background
Harmful
and/or
unnecessary
medication
use
in
older
adults
is
common.
This
indicates
deprescribing
(supervised
withdrawal
of
inappropriate
medicines)
not
happening
as
often
it
should.
study
aimed
to
synthesize
the
results
Patients’
Attitudes
Towards
Deprescribing
(PATD)
questionnaire
(and
revised
versions).
Methods
Databases
were
searched
from
January
2013
March
2020.
Google
Scholar
was
used
for
citation
searching
development
and
validation
manuscripts
identify
original
research
using
validated
PATD,
PATD
(older
adult
caregiver
versions),
version
people
with
cognitive
impairment
(rPATDcog).
Two
authors
extracted
data
independently.
A
meta-analysis
proportions
(random-effects
model)
conducted
subgroup
meta-analyses
setting
population.
The
primary
outcome
question:
“If
my
doctor
said
possible,
I
would
be
willing
stop
one
or
more
medicines.”
Secondary
outcomes
associations
between
participant
characteristics
other
(r)PATD
results.
Results
We
included
46
articles
describing
40
studies
(n
=
10,816
participants).
found
proportion
participants
who
agreed
strongly
this
statement
84%
(95%
CI
81%–88%)
80%
74%–86%)
patients
caregivers,
respectively,
significant
heterogeneity
(I2
95%
77%).
Conclusion
Consumers
reported
willingness
have
a
deprescribed
although
should
interpreted
caution
due
heterogeneity.
findings
moves
toward
understanding
attitudes
deprescribing,
which
could
increase
discussion
uptake
recommendations
clinical
practice.
BMC Geriatrics,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Sept. 25, 2023
A
third
of
older
people
take
five
or
more
regular
medications
(polypharmacy).
Conducting
medication
reviews
in
primary
care
is
key
to
identify
and
reduce/
stop
inappropriate
(deprescribing).
Recent
recommendations
for
effective
deprescribing
include
shared-decision
making
a
multidisciplinary
approach.
Our
aim
was
understand
when,
why,
how
interventions
review
involving
teams
(MDTs)
work
(or
do
not
work)
people.